Please Wait
Applying Filters...

Approved Drug Products containing 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide listed in the FDA Orange Book. Original Data : FDA Website

Menu
$ API Ref.Price (USD/KG) : 168Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4ABBVIE

02 3TARO

03 1ALMATICA

04 3AMNEAL PHARMS NY

05 3APOTEX

06 3AUROBINDO

07 1AUROBINDO PHARMA

08 4BIOVAIL LABS INTL

09 4CHARTWELL MOLECULAR

10 3CHARTWELL RX

11 3COSETTE

12 3DR REDDYS LABS LTD

13 3EPIC PHARMA

14 3EPIC PHARMA LLC

15 1FOREST LABS

16 3FOSUN PHARMA

17 3GLENMARK PHARMS LTD

18 12HERITAGE PHARMA

19 1HETERO LABS LTD III

20 1HIKMA

21 3INVAGEN PHARMS

22 3JUBILANT GENERICS

23 3MYLAN

24 2NATCO PHARMA LTD

25 9NORVIUM BIOSCIENCE

26 1PHARM ASSOC

27 3ROXANE

28 3SUN PHARM INDS INC

29 3SUN PHARM INDUSTRIES

30 3TORRENT PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CELEXA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2000-04-27

Application Number : 20822

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie Company Banner

02

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CELEXA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Approval Date : 1998-07-17

Application Number : 20822

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie Company Banner

03

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CELEXA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 40MG BASE

Approval Date : 1998-07-17

Application Number : 20822

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Abbvie Company Banner

04

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CELEXA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 60MG BASE

Approval Date : 1998-07-17

Application Number : 20822

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Abbvie Company Banner

05

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CITALOPRAM HYDROBROMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2006-03-22

Application Number : 77278

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CITALOPRAM HYDROBROMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Approval Date : 2006-03-22

Application Number : 77278

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

07

arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CITALOPRAM HYDROBROMIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 40MG BASE

Approval Date : 2006-03-22

Application Number : 77278

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CITALOPRAM HYDROBROMIDE

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 10MG BASE

Approval Date : 2005-12-20

Application Number : 21763

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

09

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CITALOPRAM HYDROBROMIDE

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 20MG BASE

Approval Date : 2005-12-20

Application Number : 21763

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

10

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

CITALOPRAM HYDROBROMIDE

Brand Name : CELEXA

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 10MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1999-12-22

Application Number : 21046

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank